Sign up to access all valuation multiples
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.
2021
5.5K+
Last FY Revenue $410M
Last FY EBITDA $95.3M
$2.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Procaps Group achieved revenue of $410M and an EBITDA of $95.3M.
Procaps Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Procaps Group valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $410M | XXX | XXX | XXX |
| Gross Profit | XXX | $240M | XXX | XXX | XXX |
| Gross Margin | XXX | 58% | XXX | XXX | XXX |
| EBITDA | XXX | $95.3M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 23% | XXX | XXX | XXX |
| EBIT | XXX | $39.0M | XXX | XXX | XXX |
| EBIT Margin | XXX | 10% | XXX | XXX | XXX |
| Net Profit | XXX | $42.5M | XXX | XXX | XXX |
| Net Margin | XXX | 10% | XXX | XXX | XXX |
| Net Debt | XXX | $243M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of September 3, 2025, Procaps Group's stock price is $1.
Procaps Group has current market cap of $2.6B, and EV of $2.8B.
See Procaps Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.8B | $2.6B | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of September 3, 2025, Procaps Group has market cap of $2.6B and EV of $2.8B.
Procaps Group's trades at 6.9x EV/Revenue multiple, and 29.6x EV/EBITDA.
Equity research analysts estimate Procaps Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Procaps Group's P/E ratio is not available.
See valuation multiples for Procaps Group and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.6B | XXX | $2.6B | XXX | XXX | XXX |
| EV (current) | $2.8B | XXX | $2.8B | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 6.9x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 29.6x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 72.4x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 60.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -161.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialProcaps Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $36K for the same period.
Procaps Group's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Procaps Group's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Procaps Group and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 23% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $36K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 23% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 49% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Procaps Group acquired XXX companies to date.
Last acquisition by Procaps Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Procaps Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Procaps Group founded? | Procaps Group was founded in 2021. |
| Where is Procaps Group headquartered? | Procaps Group is headquartered in United States of America. |
| How many employees does Procaps Group have? | As of today, Procaps Group has 5.5K+ employees. |
| Who is the CEO of Procaps Group? | Procaps Group's CEO is Mr. Ruben Minski. |
| Is Procaps Group publicy listed? | Yes, Procaps Group is a public company listed on PINX. |
| What is the stock symbol of Procaps Group? | Procaps Group trades under PROCF ticker. |
| When did Procaps Group go public? | Procaps Group went public in 2021. |
| Who are competitors of Procaps Group? | Similar companies to Procaps Group include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Procaps Group? | Procaps Group's current market cap is $2.6B |
| Is Procaps Group profitable? | Yes, Procaps Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
